Security key
45783C101
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)
CUSIP: 45783C101
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.000001 par value per share
- Total 13F shares
- 1,899,004
- Total 13F value
- $14,470,411
- Share change
- -78,314,675
- SEC-reported price per share
- $7.62
- Number of holders
- 1
- Value change
- -$293,013,435
- Number of sells
- 55
- Shares outstanding
- 6,795,789
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
1
Top holders
1
TIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45783C101
Recent filing periods:
Ownership snapshot
Top reported holders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Curative Ventures V LLC
Disclosed value leader
Curative Ventures V LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 559%
Showing 1-6 of 15 holder rows.
Quick read
Curative Ventures V LLC leads the comparable SEC ownership view at 559%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Curative Ventures V LLC's linked filing trail.
Comparable ownership
Top 5
Curative Ventures V LLC
559%
Vivo Capital, LLC
184%
CPMG Inc
121%
BAKER BROS. ADVISORS LP
69%
VANGUARD GROUP INC
39%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Curative Ventures V LLC |
13F
Company
|
559%
|
$16,255,471
37,980,073 shares
|
— | 30 Sep 2023 |
| Vivo Capital, LLC |
13F
Company
|
184%
|
$5,344,345
12,486,787 shares
|
— | 30 Sep 2023 |
| CPMG Inc |
13F
Company
|
121%
|
$3,517,504
8,218,467 shares
|
— | 30 Sep 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
69%
|
$2,013,481
4,704,395 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
39%
|
$1,143,877
2,672,610 shares
|
— | 30 Sep 2023 |
| Western Standard LLC |
13F
Company
|
26%
|
$769,110
1,796,987 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1,899,004
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
55
Q4 2023 holders
1
Holder diff
-54
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend